Effectiveness of Motivational Interview in Patients With Dyslipidemia (Dislip-EM)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified January 2011 by Hospital Universitario Reina Sofia.
Recruitment status was  Recruiting
Sponsor:
Information provided by:
Hospital Universitario Reina Sofia
ClinicalTrials.gov Identifier:
NCT01282190
First received: January 21, 2011
Last updated: NA
Last verified: January 2011
History: No changes posted
  Purpose

Evaluate the effectiveness of motivational interviewing to improve lipid control and cardiovascular risk in patients with dyslipidemia.


Condition Intervention
Patients With Dyslipidemia
Behavioral: Motivational interview

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Prevention
Official Title: Effectiveness of Motivational Interview in Patients With Dyslipidemia Treated in Primary Care Consultations (Dislip-EM Study)

Resource links provided by NLM:


Further study details as provided by Hospital Universitario Reina Sofia:

Primary Outcome Measures:
  • lipid levels [ Time Frame: 12 months ] [ Designated as safety issue: Yes ]

Secondary Outcome Measures:
  • cardiovascular risk [ Time Frame: 12 months ] [ Designated as safety issue: Yes ]

Estimated Enrollment: 400
Study Start Date: June 2010
Estimated Primary Completion Date: January 2011 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Motivational interview Behavioral: Motivational interview
Motivational interview

  Eligibility

Ages Eligible for Study:   40 Years to 75 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • People diagnosed with dyslipidemia
  • To sign informed consent.

Exclusion Criteria:

  • Secondary hypercholesterolemia.
  • Familial hypercholesterolemia.
  • Deficiency syndromes family high density lipoprotein.
  • Subjects with a history of cardiac or cerebrovascular events.
  • Other chronic health problems such as diabetes or severe COPD.
  • Subjects with current diagnosis of cancer.
  • Patients with hepatic or renal disorders .
  • Subjects heavy drinkers.
  • Patients with long standing sick leave (more than 6 months).
  • Pregnant or breastfeeding.
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01282190

Contacts
Contact: Luis A Pérula, Ph D +34 957012543 langel.perula.sspa@juntadeandalucia.es

Locations
Spain
Family Medicine Teaching Unit and Community Recruiting
Córdoba, Spain, 14011
Contact: Luis A Pérula, Ph D    +34 957012543    langel.perula.sspa@juntadeandalucia.es   
Principal Investigator: Luis A Pérula, Ph D         
Sponsors and Collaborators
Hospital Universitario Reina Sofia
  More Information

No publications provided by Hospital Universitario Reina Sofia

Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: Luis A Pérula, Biomedical Research Foundation of Cordoba (FIBICO)
ClinicalTrials.gov Identifier: NCT01282190     History of Changes
Other Study ID Numbers: PI-0100/2008
Study First Received: January 21, 2011
Last Updated: January 21, 2011
Health Authority: Spain: Autonomic Committee of Clinical Trials (Andalusian)

Keywords provided by Hospital Universitario Reina Sofia:
dyslipidemia, motivational interview, prevention

Additional relevant MeSH terms:
Dyslipidemias
Lipid Metabolism Disorders
Metabolic Diseases

ClinicalTrials.gov processed this record on April 15, 2014